Visual Impairment in Patients with Giant Cell Arteritis Treated with Tocilizumab in Real-World Clinical Practice

Update item information
Identifier 20190319_nanos_sciplatform3_08_slides
Title Visual Impairment in Patients with Giant Cell Arteritis Treated with Tocilizumab in Real-World Clinical Practice
Creator Timothy McCulley, Jinglan Pei, Paris Sidiropoulos, Christine Birchwood, Jennie Best, John Stone, Sebastian Unizony
Subject Vascular Disorders
Description The GiACTA trial demonstrated the efficacy of tocilizumab (TCZ) in giant cell arteritis (GCA) [1]. However, the effectiveness of TCZ for prevention of specific GCA-related visual manifestations is currently unknown. The incidence of GCA-related visual manifestations was analyzed in patients treated with TCZ in a real-world setting.
Relation is Part of NANOS 2019: Scientific Platform III
Contributor Primary Timothy McCulley
Contributor Secondary Jinglan Pei, Paris Sidiropoulos, Christine Birchwood, Jennie Best, John Stone, Sebastian Unizony
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Date 2019-03
Format application/pdf
Source 2019 North American Neuro-Ophthalmology Society Annual Meeting
Rights Management Copyright 2019. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Language eng
ARK ark:/87278/s6090s4x
Setname ehsl_novel_nam
Date Created 2019-09-10
Date Modified 2019-09-10
ID 1455040
Reference URL https://collections.lib.utah.edu/ark:/87278/s6090s4x
Back to Search Results